Exploring Impediments to the Proliferation of Commercial Unmanned Aerial System Use in the National Airspace System of the United States
Muma Business Review · 2018
DOI: 10.28945/4145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muma Business Review, 2018. Verfasst von Darren Spencer. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The UAS industry is experiencing a rapid expansion, doubling every year since 2013, as adopters of this disruptive technology find new ways to benefit from these aerial platforms (Spencer, 2018). Of particular interest is the use of small to medium sized UASs, with a cost to the user of less than $2,000 that are the catalyst for this growth. Despite this rapid growth, UAS operators claim an inability to use these systems to their full potential due to regulatory obstacles. A collection of industry experts were interviewed to discuss the UAS industry, and to explore these perceived obstacles that may be hindering an increased use of these systems across the United States. Represented in the body of 12 interviewees were UAS operators, academic experts, UAS reporters, and legal and regulatory professionals from across the country with on average at least five years of experience in UASs, and at least 10 years in aviation to provide a breadth of experience and array of viewpoints.
Zitieren
APA
Spencer, D. (2018). Exploring Impediments to the Proliferation of Commercial Unmanned Aerial System Use in the National Airspace System of the United States. Muma Business Review. https://doi.org/10.28945/4145
Vancouver
Spencer D. Exploring Impediments to the Proliferation of Commercial Unmanned Aerial System Use in the National Airspace System of the United States. Muma Business Review. 2018. doi:10.28945/4145
BibTeX
@article{Spencer2018,
author = {Spencer, Darren},
title = {Exploring Impediments to the Proliferation of Commercial Unmanned Aerial System Use in the National Airspace System of the United States},
journal = {Muma Business Review},
year = {2018},
doi = {10.28945/4145}
}
EUVIMED